These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 18356443)
1. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations. Chen Y; Li Y; Zhu Q; Zeng Q; Zhao J; He X; Mei Q AJR Am J Roentgenol; 2008 Apr; 190(4):966-71. PubMed ID: 18356443 [TBL] [Abstract][Full Text] [Related]
2. Treatment of orbital vascular malformations with intralesional injection of pingyangmycin. Yue H; Qian J; Elner VM; Guo J; Yuan YF; Zhang R; Ge Q Br J Ophthalmol; 2013 Jun; 97(6):739-45. PubMed ID: 23603483 [TBL] [Abstract][Full Text] [Related]
3. Pingyangmycin as first-line treatment for low-flow orbital or periorbital venous malformations: evaluation of 33 consecutive patients. Jia R; Xu S; Huang X; Song X; Pan H; Zhang L; He F; Lin M; Ge S; Fan X JAMA Ophthalmol; 2014 Aug; 132(8):942-8. PubMed ID: 24723045 [TBL] [Abstract][Full Text] [Related]
4. [Percutaneous intratumoral injection with pingyangmycin lipiodol emulsion for treatment of recurrent sacrococcygeal chordomas]. Guan JY; Wang BB; Wei CJ; Li YH Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2366-9. PubMed ID: 20965848 [TBL] [Abstract][Full Text] [Related]
5. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children. Abdelaziz O; Hassan F; Elessawy K; Emad-Eldin S; Essawy RE Cardiovasc Intervent Radiol; 2019 Mar; 42(3):433-440. PubMed ID: 30488306 [TBL] [Abstract][Full Text] [Related]
6. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin. Liu Y; Liu D; Wang Y; Zhang W; Zhao F J Oral Maxillofac Surg; 2009 Jan; 67(1):98-104. PubMed ID: 19070754 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous intratumoral injection with pingyangmycin lipiodol emulsion for the treatment of recurrent sacrococcygeal chordomas. Guan JY; He XF; Chen Y; Zeng QL; Mei QL; Li YH J Vasc Interv Radiol; 2011 Aug; 22(8):1216-20. PubMed ID: 21801998 [TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations. Jin Y; Lin X; Li W; Hu X; Ma G; Wang W J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776 [TBL] [Abstract][Full Text] [Related]
9. Multimodality Image-Guided Sclerotherapy of Low-Flow Orbital Vascular Malformations: Report of Single-Center Experience. Harmoush S; Chinnadurai P; El Salek K; Metwalli Z; Herce H; Bhatt A; Steinkuller P; Vece T; Siddiqui S; Pimpalwar A; Marx D; Mawad M; Pimpalwar S J Vasc Interv Radiol; 2016 Jul; 27(7):987-995.e4. PubMed ID: 27184528 [TBL] [Abstract][Full Text] [Related]
10. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. Zhao JH; Zhang WF; Zhao YF Int J Oral Maxillofac Surg; 2004 Jul; 33(5):463-6. PubMed ID: 15183410 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin. Chen WL; Huang ZQ; Zhang DM; Chai Q Head Neck; 2010 Apr; 32(4):467-72. PubMed ID: 19672870 [TBL] [Abstract][Full Text] [Related]
12. Orbital venous malformations: current multidisciplinary treatment approach. Arat YO; Mawad ME; Boniuk M Arch Ophthalmol; 2004 Aug; 122(8):1151-8. PubMed ID: 15302655 [TBL] [Abstract][Full Text] [Related]
13. Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients. Zheng JW; Yang XJ; Wang YA; He Y; Ye WM; Zhang ZY Oral Oncol; 2009 Oct; 45(10):872-6. PubMed ID: 19628423 [TBL] [Abstract][Full Text] [Related]
14. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. Bai Y; Jia J; Huang XX; Alsharif MJ; Zhao JH; Zhao YF J Oral Maxillofac Surg; 2009 Feb; 67(2):251-6. PubMed ID: 19138596 [TBL] [Abstract][Full Text] [Related]
15. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region. Zhi K; Wen Y; Li L; Ren W Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):593-7. PubMed ID: 18294701 [TBL] [Abstract][Full Text] [Related]
16. Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy. Shigematsu T; Sorscher M; Dier EC; Berenstein A J Neurointerv Surg; 2019 Jan; 11(1):57-61. PubMed ID: 29674482 [TBL] [Abstract][Full Text] [Related]
17. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632 [TBL] [Abstract][Full Text] [Related]
18. Patients with intralesional hemorrhage in venous malformations: diagnosis and embolosclerotherapy. Chen H; Lin X; Jin Y; Li W; Ma G; Hu X J Vasc Surg; 2009 Feb; 49(2):429-33; discussion 433-4. PubMed ID: 18945573 [TBL] [Abstract][Full Text] [Related]
19. [Intravascular administration of pingyangmycin lipiodol emulsion for Klippel-Trenaunay syndrome: clinical analysis of 7 cases]. Kong WD; Yi YH; He XF; Chen Y; Zeng QL; Lu W; Zhao JB Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1109-11. PubMed ID: 14559711 [TBL] [Abstract][Full Text] [Related]
20. Bleomycin sclerotherapy of a distensible orbital venous malformation without image guidance. Chen Y; Choi CJ; Lee BW Can J Ophthalmol; 2019 Jun; 54(3):e120-e123. PubMed ID: 31109497 [No Abstract] [Full Text] [Related] [Next] [New Search]